

Sept 1 (Reuters) - AstraZeneca has expanded its agreement with Oxford Biomedica to make and supply the drugmaker's COVID-19 vaccine candidate, in a ...


(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new development, manufacture and license agreement with Beam Therapeuti...


IN BRIEF: Oxford Biomedica And Axovant Sign Clinical Supply Deal


(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a three-year clinical supply agreement with a wholly-owned subsidiary of ...


LONDON BRIEFING: Ryanair Expect 60% Drop In Passengers In Current Year


(Sharecast News) - A Covid-19 vaccine backed by AstraZeneca is producing positive results in initial trials, according to a report.


DIRECTOR DEALINGS: Oxford Biomedica Director's Associate Buys Shares


DIRECTOR DEALINGS: Oxford BioMedica Non-Exec Sells GBP1.8 Million